Poop pills plus immunotherapy: new hope for lung cancer?
Disease control
Not yet recruiting
This study tests whether a fecal microbiota transplant (FMT) combined with the drug tislelizumab can help people with advanced non-small cell lung cancer whose disease got worse after standard immunotherapy. The goal is to see if changing gut bacteria can restore the immune syste…
Phase: PHASE2 • Sponsor: Se-Hoon Lee • Aim: Disease control
Last updated Apr 29, 2026 01:51 UTC